Johannes Grisar

The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? (2008)

Smolen, Josef S, Aletaha, Daniel, Grisar, Johannes, Redlich, Kurt, Steiner, Günter, Wagner, Oswald

Abstract Rheumatoid arthritis is a heterogeneous disease with respect to clinical manifestations, serologic abnormalities, joint damage and functional impairment. Predicting outcome in a reliable way...

The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function (2005)

Kirsch, Bernhard M, Zeyda, Maximilian, Stuhlmeier, Karl, Grisar, Johannes, Smolen, Josef S, Watschinger, Bruno, ...

Abstract Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis (RA), exhibits anti-inflammatory, antiproliferative and immunosuppressive effects....

Phenotypic characteristics of human monocytes undergoing transendothelial migration (2001)

Grisar, Johannes, Hahn, Philipp, Brosch, Susanne, Peterlik, Meinrad, Smolen, Josef S, Pietschmann, Peter

Abstract In our study we characterised the immunophenotype of monocytes that migrated through an endothelial cell (EC) monolayer in vitro . We found that monocyte migration led to an enhanced...

Phenotypic characteristics of human monocytes undergoing transendothelial migration

Grisar, Johannes, Hahn, Philipp, Brosch, Susanne, Peterlik, Meinrad, Smolen, Josef S, Pietschmann, Peter

In our study we characterised the immunophenotype of monocytes that migrated through an endothelial cell (EC) monolayer in vitro. We found that monocyte migration led to an enhanced expression of...

The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function

Kirsch, Bernhard M, Zeyda, Maximilian, Stuhlmeier, Karl, Grisar, Johannes, Smolen, Josef S, Watschinger, Bruno, ...

Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis (RA), exhibits anti-inflammatory, antiproliferative and immunosuppressive effects. Although...

Phenotypic characteristics of human monocytes undergoing transendothelial migration

Grisar, Johannes, Hahn, Philipp, Brosch, Susanne, Peterlik, Meinrad, Smolen, Josef S, Pietschmann, Peter

In our study we characterised the immunophenotype of monocytes that migrated through an endothelial cell (EC) monolayer in vitro. We found that monocyte migration led to an enhanced expression of...

The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function

Kirsch, Bernhard M, Zeyda, Maximilian, Stuhlmeier, Karl, Grisar, Johannes, Smolen, Josef S, Watschinger, Bruno, ...

Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis (RA), exhibits anti-inflammatory, antiproliferative and immunosuppressive effects. Although...

The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?

Smolen, Josef S, Aletaha, Daniel, Grisar, Johannes, Redlich, Kurt, Steiner, Günter, Wagner, Oswald

Rheumatoid arthritis is a heterogeneous disease with respect to clinical manifestations, serologic abnormalities, joint damage and functional impairment. Predicting outcome in a reliable way to allow...